Yaakov Lavie

2.3k total citations
26 papers, 2.0k citations indexed

About

Yaakov Lavie is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Yaakov Lavie has authored 26 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Cell Biology and 10 papers in Oncology. Recurrent topics in Yaakov Lavie's work include Drug Transport and Resistance Mechanisms (10 papers), Caveolin-1 and cellular processes (10 papers) and Sphingolipid Metabolism and Signaling (7 papers). Yaakov Lavie is often cited by papers focused on Drug Transport and Resistance Mechanisms (10 papers), Caveolin-1 and cellular processes (10 papers) and Sphingolipid Metabolism and Signaling (7 papers). Yaakov Lavie collaborates with scholars based in Israel, United States and United Kingdom. Yaakov Lavie's co-authors include Mordechai Liscovitch, Giusy Fiucci, Armando E. Giuliano, Myles C. Cabot, Malgorzata Czarny, Hui-Ting Cao, Stuart L. Bursten, Tie-Yan Han, Anthony Lucci and Jan Krzysztof Blusztajn and has published in prestigious journals such as Journal of Biological Chemistry, Advanced Drug Delivery Reviews and Trends in Biochemical Sciences.

In The Last Decade

Yaakov Lavie

26 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yaakov Lavie Israel 22 1.5k 647 556 291 194 26 2.0k
Robert Jan Veldman Netherlands 20 1.4k 0.9× 387 0.6× 307 0.6× 378 1.3× 122 0.6× 29 1.8k
Anutosh Chakraborty United States 23 1.3k 0.9× 529 0.8× 619 1.1× 244 0.8× 246 1.3× 36 2.2k
Jean‐Pierre Jaffrézou France 29 2.1k 1.4× 388 0.6× 451 0.8× 389 1.3× 104 0.5× 45 2.7k
Tie-Yan Han United States 20 1.8k 1.2× 247 0.4× 505 0.9× 202 0.7× 94 0.5× 21 2.1k
Marian B. Meyers United States 27 2.2k 1.5× 275 0.4× 1.2k 2.2× 175 0.6× 170 0.9× 39 3.1k
David A. Rudnick United States 32 1.4k 0.9× 494 0.8× 344 0.6× 155 0.5× 575 3.0× 58 2.8k
Dominique Ardail France 24 1.6k 1.1× 322 0.5× 351 0.6× 202 0.7× 95 0.5× 60 2.2k
David Raden United States 16 1.7k 1.1× 849 1.3× 277 0.5× 136 0.5× 174 0.9× 21 2.3k
Anja Jaeschke United States 21 1.6k 1.1× 351 0.5× 325 0.6× 429 1.5× 240 1.2× 30 2.5k
Masatoshi Inoue Japan 18 1.4k 1.0× 461 0.7× 156 0.3× 216 0.7× 305 1.6× 42 2.1k

Countries citing papers authored by Yaakov Lavie

Since Specialization
Citations

This map shows the geographic impact of Yaakov Lavie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaakov Lavie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaakov Lavie more than expected).

Fields of papers citing papers by Yaakov Lavie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaakov Lavie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaakov Lavie. The network helps show where Yaakov Lavie may publish in the future.

Co-authorship network of co-authors of Yaakov Lavie

This figure shows the co-authorship network connecting the top 25 collaborators of Yaakov Lavie. A scholar is included among the top collaborators of Yaakov Lavie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaakov Lavie. Yaakov Lavie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lavie, Yaakov, et al.. (2021). Post-SSRI Sexual Dysfunction (PSSD): Biological Plausibility, Symptoms, Diagnosis, and Presumed Risk Factors. Sexual Medicine Reviews. 10(1). 91–98. 23 indexed citations
2.
Ravid, Dana, Dana Chuderland, Limor Landsman, et al.. (2008). Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration. Experimental Cell Research. 314(15). 2762–2773. 58 indexed citations
3.
Liscovitch, Mordechai & Yaakov Lavie. (2000). Multidrug resistance: a role for cholesterol efflux pathways?. Trends in Biochemical Sciences. 25(11). 530–534. 56 indexed citations
4.
Lavie, Yaakov, et al.. (2000). Changes in lipid and protein constituents of rafts and caveolae in multidrug resistant cancer cells and their functional consequences. Glycoconjugate Journal. 17(3-4). 253–259. 81 indexed citations
5.
Fiucci, Giusy, Malgorzata Czarny, Yaakov Lavie, et al.. (2000). Changes in phospholipase D isoform activity and expression in multidrug-resistant human cancer cells. International Journal of Cancer. 85(6). 882–888. 32 indexed citations
6.
Czarny, Malgorzata, Giusy Fiucci, Yaakov Lavie, et al.. (2000). Phospholipase D2: functional interaction with caveolin in low‐density membrane microdomains. FEBS Letters. 467(2-3). 326–332. 36 indexed citations
7.
Czarny, Malgorzata, Yaakov Lavie, Giusy Fiucci, & Mordechai Liscovitch. (1999). Localization of Phospholipase D in Detergent-insoluble, Caveolin-rich Membrane Domains. Journal of Biological Chemistry. 274(5). 2717–2724. 104 indexed citations
8.
Liscovitch, Mordechai, et al.. (1999). Localization and possible functions of phospholipase D isozymes. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1439(2). 245–263. 130 indexed citations
9.
Lavie, Yaakov, Giusy Fiucci, & Mordechai Liscovitch. (1998). Up-regulation of Caveolae and Caveolar Constituents in Multidrug-resistant Cancer Cells. Journal of Biological Chemistry. 273(49). 32380–32383. 254 indexed citations
10.
Lavie, Yaakov, Hui-Ting Cao, Tie-Yan Han, et al.. (1998). Tamoxifen induces selective membrane association of protein kinase C epsilon in MCF-7 human breast cancer cells. International Journal of Cancer. 77(6). 928–932. 45 indexed citations
11.
12.
Cabot, Myles C., et al.. (1997). Tamoxifen activates cellular phopholipase C and D and elicits protein kinase C translocation. International Journal of Cancer. 70(5). 567–574. 39 indexed citations
13.
Lavie, Yaakov, et al.. (1997). Wortmannin Blocks Goldfish Retinal Phosphatidylinositol 3-Kinase and Neurite Outgrowth. Neurochemical Research. 22(4). 373–378. 12 indexed citations
14.
Lavie, Yaakov & Bernard W. Agranoff. (1996). Inhibition of Neuroblastoma Cell Phosphatidylinositol 3‐Kinase by CDP‐Diacylglycerol and Phosphatidate. Journal of Neurochemistry. 66(2). 811–816. 6 indexed citations
15.
Lavie, Yaakov, Hui-Ting Cao, Stuart L. Bursten, Armando E. Giuliano, & Myles C. Cabot. (1996). Accumulation of Glucosylceramides in Multidrug-resistant Cancer Cells. Journal of Biological Chemistry. 271(32). 19530–19536. 295 indexed citations
16.
Lavie, Yaakov & Bernard W. Agranoff. (1996). Carbachol Inhibits Insulin‐Stimulated Phosphatidylinositol 3‐Kinase Activity in SH‐SY5Y Neuroblastoma Cells. Journal of Neurochemistry. 67(3). 1245–1251. 7 indexed citations
17.
Lavie, Yaakov, Jan Krzysztof Blusztajn, & Mordechai Liscovitch. (1994). Formation of endogenous free sphingoid bases in cells induced by changing medium conditions. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1220(3). 323–328. 21 indexed citations
18.
Lavie, Yaakov, et al.. (1992). Bimodal distribution of phosphatidic acid phosphohydrolase in NG108–15 cells. European Journal of Biochemistry. 204(2). 561–568. 24 indexed citations
19.
Liscovitch, Mordechai & Yaakov Lavie. (1991). Sphingoid bases as endogenous cationic amphiphilic “drugs”. Biochemical Pharmacology. 42(11). 2071–2075. 27 indexed citations
20.
Liscovitch, Mordechai & Yaakov Lavie. (1990). Sphingoid Bases: Sphingolipid-Derived Modulators of Signal Transduction. Trends in Glycoscience and Glycotechnology. 2(8). 470–485. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert Jan Veldman Breakdown of academic impact, for papers by Anutosh Chakraborty Breakdown of academic impact, for papers by Jean‐Pierre Jaffrézou Breakdown of academic impact, for papers by Tie-Yan Han Breakdown of academic impact, for papers by Marian B. Meyers Breakdown of academic impact, for papers by David A. Rudnick Breakdown of academic impact, for papers by Dominique Ardail Breakdown of academic impact, for papers by David Raden Breakdown of academic impact, for papers by Anja Jaeschke Breakdown of academic impact, for papers by Masatoshi Inoue
Rankless by CCL
2026